UnitedHealth Group’s Health Services Business Creates Optum Ventures, a $250M Venture Fund

UnitedHealth Group (UNH)’s Optum health services business announced recently the creation of Optum Ventures, a $250M venture fund focused on investing in startup and early-stage companies whose innovations will help advance the health care system.

Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 133,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (UNH).

Optum Ventures specifically invests in digital health companies that use data and insights to help improve consumers’ access to health care services and how care is delivered and paid for, and that make the health care system more reliable and easier to navigate.

To learn more about UnitedHealth Group (UNH) and to track its ongoing progress please visit the Vista Partners UnitedHealth Group Coverage Page.

Optum Announces $250 Million Fund to Invest in Next Generation of Health Care Innovation

Optum, the health services business of UnitedHealth Group , announced today the creation of Optum Ventures, a $250 million venture fund focused on investing in startup and early-stage companies whose innovations will help advance the health care system…

finance.yahoo.com

Read Full Article



Aetna CEO Mark Bertolini Interview on Healthcare’s Future Focus & CVS Buyout

Today news broke on a buyout of Aetna by CVS for a reported $69 Billion which could significantly alter the future of healthcare.

CVS CEO Larry Merlo stated, “This combination brings together the expertise of two great companies to remake the consumer healthcare experience. With the analytics of Aetna and CVS Health’s human touch, we will create a healthcare platform built around individuals.”

Aetna CEO Mark Bertolini stated, “Together with CVS Health, we will better understand our members’ health goals, guide them through the health care system and help them achieve their best health.”

In an interview recently, accessed via the curated story below, you will find what I believe to be a must-see interview of Aetna CEO Mark Bertolini. I found the interview quite interesting and candid insight into the state of healthcare in the US and how the basic premise and system must be changed to focus on addressing the well being of individuals vs treating the sick. He stated,  “I think we should define health is a healthy person is productive, a productive person is socially, economically, and physically viable and viable people are happy.”

Please take the time to hear him out!

 

Aetna CEO Mark Bertolini on the future of healthcare

Aetna CEO Mark Bertolini speaks with Yahoo Finance’s Julia La Roche about the future of healthcare at the Yahoo Finance All Markets Summit…

finance.yahoo.com

Read Full Article



How Do You Like The Sound of “24K”?

Vista Partners has published its Weekly Market Update for the week of December 2, 2017, titled “24K” Vista Partners Weekly Market Update 12-2-2017 and is accessible on our Newsletters Page. Each issue is written by Managing Director, John Heerdink and speaks to the activities of the market, influencers and specific featured stories from Vista’s Coverage Universe that spans the Dow 30 and Select Emerging Growth Companies.

Each weekly update issue is sent out via email directly to the thousands of investors around the world that have elected to be updated each week.  Please “Join us” to Stay Informed! and to Stay Competitive!

It’s FREE & EASY to sign up.

Have a great weekend!




Pfizer Granted Rights to Develop Novel Antifungal Medicine in Asia

Pfizer (PFE)  is a leading global provider of anti-infective medicines, offering patients access to a diverse portfolio of more than 80 products.

Recently, Pfizer Inc. (PFE) and Basilea Pharmaceutica Ltd. (BSLN.SW), an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines,  announced they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization rights in China and several countries in the Asia Pacific region to CRESEMBA (isavuconazole). CRESEMBA is a novel antifungal medicine for the treatment of adult patients with diagnosed invasive aspergillosis and mucormycosis1, two serious infections associated with significant morbidity and mortality among immunocompromised patients, such as those with advanced HIV and those with cancer.

Pfizer will have exclusive rights to develop, distribute and commercialize CRESEMBA in sixteen Asian Pacific countries and China (including Hong Kong and Macao). These rights do not include Japan. In addition, Pfizer will become the marketing authorization holder for the Asia Pacific Region and China. The specific financial terms of the agreement remain confidential. The agreement is subject to customary regulatory approval.

CRESEMBA was developed in response to the urgent medical need for antifungal medicines for the treatment of invasive fungal infections, which are naturally resistant to many antifungal therapies and have become increasingly resistant to other available therapies.

To learn more about Pfizer (PFE) and to track its progress please visit the Vista Partners Pfizer Coverage Page.

Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region

Pfizer Inc. and Basilea Pharmaceutica Ltd. , an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, today announced they have entered into an agreement whereby Pfizer will be granted the exclusive development and commercialization..

finance.yahoo.com

Read Full Article



Cloud Services Provider Fusion (FSNN) Wins Contracts in Healthcare and Hospitality

New York City, NY based Fusion’s (FSNN) advanced cloud voice and connectivity solutions has been selected to improve communications for two major enterprises in the healthcare and hospitality while the contracts are worth more than $1.6 million.Fusion reported that the customers cited Fusion’s expertise in meeting the specialized requirements of these key industries. The first multi-location solution was engineered to improve communications across the 35 locations of a rapidly expanding provider of administrative services to nursing homes in five states in the southeastern states in the U.S.

Russell P. Markman, Fusion’s President of Business Services, stated, “Fusion is committed to meeting the rigorous requirements of this growing organization, which recognized our experience in healthcare and our own dedication to service excellence.  This leading provider of administrative services was looking for a partner that understands the complex demands of the nursing home industry and was impressed with our ability to deliver a level of service consistent with its own commitment to its nursing home customers, employees and the seniors under their care. Each of these growing enterprises prides itself on delivering an exceptional experience to its expanding customer base.  We are delighted that they have chosen Fusion to meet their highly specialized needs now and in the future.”

To learn more about Fusion (Nasdaq: FSNN) and to track its progress please visit the Vista Partners Fusion (FSNN) Coverage Page.

FSNN closed Friday’s trading at or $3.76 near its 52-week high of $3.80 and now averages 450,441 shares a day.

Vista recently issued an update report on FSNN dated November 20, 2017 when the stock was trading at $2.85/share. Download the FREE FSNN Report.




Vista Partners Recently Published An Update Report on Health Insurance Innovations, Inc. (NASDAQ: HIIQ)

Recently, Vista Partners published a FREE update research report on Emerging Growth Company & affordable, web-based individual health insurance plans provider, Health Insurance Innovations, Inc. (NASDAQ: HIIQ).  Please review the report on Vista Partners Health Insurance Innovations, Inc. Coverage Page found within the Featured Coverage Pages at Vista Partners. Vista’s Coverage Pages are designed to provide an understanding of the company’s current business, financials, strategy, products, and pipeline. Stay Informed! Stay Competitive!




Vista Partners Recently Published An Update Report on Cloud Services Provider Fusion (NASDAQ: FSNN)

Recently, Vista Partners published a FREE update research report on Emerging Growth Company & Cloud Services Provider Fusion (NASDAQ: FSNN).  Please review the report on Vista Partners Fusion Coverage Page found within the Featured Coverage Pages at Vista Partners. Vista’s Coverage Pages are designed to provide an understanding of the company’s current business, financials, strategy, products, and pipeline. Stay Informed! Stay Competitive!




Vista Partners Publishes Update Report on Dow 30 Component Chevron (NYSE: CVX)




Vista Partners Publishes Update Report on Dow 30 Component Wal-Mart (NYSE: WMT)




“Will the Bull Market Continue to Run?” Vista Partners Publishes November Macroeconomic & Investment Newsletter

Vista Partners (“Vista”) has published November’s FREE Macroeconomic & Investment Monthly Newsletter, “Will the Bull Market Continue to Run?”

Vista’s monthly newsletter contains investment considerations for Biotech, Cloud Services, Energy, Fintech, Healthcare, Manufacturing, Materials, SaaS, and Technology.

Vista Partners centers its Coverage on the Dow 30 Components, Select Emerging Growth Companies & Vista’s Featured Companies, with exclusive, broad-based commentary from Managing Director, John F. Heerdink, Jr.

In November’s edition of the Macroeconomic & Investment Newsletter, Mr. Heerdink states, “The stock market itself may be right in that…” Read full newsletter.

Companies Featured in November’s Newsletter: Apple, Inc. (AAPL) | Atossa Genetics, Inc. (NASDAQ: ATOS) | Fusion, Inc. (NASDAQ: FSNN) | Merck & Co., Inc. (MRK), & Visa Inc. (V).

Vista Partners publishes 100% of its content free. To receive free email updates from Vista’s extensive coverage universe, please sign up at VistaPGlobal.com/signup.

About Vista Partners LLC:

Founded in 2005, Vista Partners LLC (“Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, and Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

We encourage readers to view a complete list of disclaimers and disclosures on the Vista Partners website at VistaPGlobal.com/disclaimer.

Please follow Vista Partners on Twitter @VistaPResearch to receive updates, thoughts, and ideas on Dow 30 Components, Select Emerging Growth Companies & Vista’s Featured Companies.